An African, Multi-centre Evaluation of Patient Care and Clinical Outcomes for Paediatric Patients Undergoing Surgery
A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis
ASia Pacific Evaluation of Chest pain Trial
ASian Paclitaxel-Eluting stent Clinical Trial
Aspirin and Esomeprazole Chemoprevention in Barrett's metaplasia Trial
ASpirin-induced Platelet EffeCT study
Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis 2
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia
Alberta Stroke Program Early CT Score
A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia
A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis
Alexander technique and Supervised Physiotherapy Exercises in back pain
Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma
Atorvastatin Study for Prevention of coronary heart disease Endpoints in NIDDM
A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma
Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19
Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care
Addition of Spironolactone in Patients with Resistant Arterial Hypertension
Asian Pacific trial of Tarceva as first-line in EGFR mutation
A Study Promoting the Influenza Response in the Elderly
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Action on Secondary Prevention through Intervention to Reduce Events
Active controlled Study of Patients receiving Infliximab for treatment of Rheumatoid arthritis of Early onset
Adherence to SPIrit REcommendations
Aliskiren Study in Post-MI patients to Reduce rEmodeling
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Arixtra Study in Percutaneous coronary Intervention - a Randomized Evaluation pilot trial
Aspirin to prevent recurrent venous thromboembolism
AutoPulse Assisted Prehospital International Resuscitation Trial
Carfilzomib, Lenalidomide, and Dexamethasone for relapsed multiple myeloma
Multi-arm trials and strategies to address multiple testing
The effect of a trAnSitional Pharmacist Intervention in geRiatric inpatients on hospital visits after discharge
Automation to Simulate Pancreatic Insulin REsponse In-Home
Adherence to SPIrit Recommendations in Switzerland, CAnada and Germany
Adherance to SPIrit REcommendations in the UK
Multi-centre open-label randomised controlled trial of immediate enhanced ambulatory ECG monitoring versus standard monitoring in acute unexplained syncope patients
A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas
Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral haemorrhaGe
ASpirin for evidence-based PREeclampsia prevention
ASPirin in Reducing Events in the Elderly (1)
ASPirin in Reducing Events in the Elderly (2)
ASPirin in Reducing Events in the Elderly-AMD
Aspirin for the prevention of Depression in the elderly
Low-dose aspirin for the prevention of fractures in healthy older people
ASPIRIN in Hearing, retinal vessels imaging and neurocognition in older people
ASPirin in Reducing Events in the Elderly
ASPirin in Reducing Events in the Elderly NEUROimaging sub-study
Aspirin Use in Participants at the Baseline of the ASPirin in Reducing Events in the Elderly – eXTension
ASPirin in Reducing Events in the Elderly - eXTension
Australian Swedish Pindolol Study
Austrian Stroke Prevention Study
ASsessment of the Safety and Efficacy of a New Thrombolytic agent Plus
ASsessment of the Safety and Efficacy of a New Thrombolytic agent-1
ASsessment of the Safety and Efficacy of a New Thrombolytic agent-2
ASsessment of the Safety and Efficacy of a New Thrombolytic agent-2 ECG/VCG
ASsessment of the Safety and Efficacy of a New Thrombolytic agent-3
ASsessment of the Safety and Efficacy of a New Thrombolytic agent-3 PLUS